Name: Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate (Video) | JoVE Journal
Uploaded: 2021-10-29T14:00:00.000+00:00
Duration: 6 min 3 s
Description: Learn a rapid, affordable method for producing bacterial cell-free lysate using an autolysis Escherichia coli strain and standard laboratory equipment. This protocol enables accessible cell-free gene expression for researchers.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors thank Zachary Sun and Richard Murray (California Institute of Technology) for kindly providing the plasmid P_araBAD-gamS, and Kaeko Kamei (Kyoto Institute of Technology) for kindly providing a high-speed cooling centrifuge. This work was supported by grants from the National Institutes of Health and from the ARO MURI program and was partly supported by the Leading Initiative for Excellent Young Researchers, MEXT, Japan.

1. Prepare media and buffers.
<ol>
	<li>Prepare 2xYTPG medium.
	<ol>
		<li>Mix 62 g 2xYT powder, 5.99 g potassium phosphate monobasic, 13.93 g potassium phosphate dibasic, and deionized water to 2 L.</li>
		<li>Autoclave on liquid cycle with an exposure time of 30 min14.</li>
		<li>To 400 mL of 2xYTP media from 1.1.2, add 7.2 g D-glucose (dextrose) and mix until dissolved.</li>
		<li>Filter-sterilize through a 0.2 &#181;m filter.</li>
	</ol>
	</li>
	<li>Prepare S30A buffer.
	<ol>
		<li>Mix Tris-HCl (pH 7.7, 50 mM final concentration), potassium glutamate (60 mM final), and magnesium glutamate (14 mM final).</li>
		<li>Adjust the pH to 7.7 using 10 M KOH.</li>
	</ol>
	</li>
	<li>Prepare Solution 1 (see Table 1).
	<ol>
		<li>Resuspend 4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid (HEPES) in 2 mL of water.</li>
		<li>Adjust the pH to 8.0 using KOH.</li>
		<li>Add all other components from Table 1.</li>
		<li>Adjust the pH to 7.6 using 10 M KOH. Filter-sterilize.</li>
	</ol>
	</li>
	<li>Prepare 2.5x premix solution (see Table 2).
	<ol>
		<li>Mix all the components in Table 2.</li>
		<li>Adjust the pH to 7.5 using KOH.</li>
		<li>Aliquot and freeze at -80 &#176;C. 
		&#8203;NOTE: A 20 &#181;L reaction uses 8.9 &#181;L of premix.</li>
	</ol>
	</li>
</ol>
2. Prepare cells.
<ol>
	<li>Streak the autolysate cells onto LB agar plates containing 50 &#181;g/mL ampicillin using an inoculating loop and grow at 37 &#176;C (see Note 1).</li>
	<li>Pick a single colony into a starter culture of LB/ampicillin medium using a pipet tip and grow at 37 &#176;C overnight.</li>
	<li>Inoculate 400 mL of 2xYTPG medium containing 50 &#181;g/mL ampicillin with 400 &#181;L of starter culture, and grow at 37 &#176;C in a 1 L Erlenmeyer flask, shaking at 300 rpm.</li>
	<li>Periodically measure the culture&#39;s optical density at 600 nm (OD600) using a spectrophotometer to read an optical cuvette with a 1 cm path length. When the OD600 exceeds 1, begin diluting the culture 5-fold before measurements to ensure that the measurements remain within the linear range of a typical laboratory spectrophotometer. Continue growing the cells until the 5-fold diluted culture reaches OD600 of 0.3 (corresponding to a culture OD600 of 1.5).</li>
</ol>
3. Prepare the lysate.
<ol>
	<li>Prepare S30A buffer supplemented with 2 mM dithiothreitol (DTT). Mix 3&#160;mL of S30A buffer with 6&#160;&#181;L of DTT stock solution at 1 M. Place on ice for use in step 3.7.</li>
	<li>Harvest the cells by centrifuging at 1800 &#215; g for 15 min at room temperature.</li>
	<li>Discard the supernatant by pouring it off and using a pipet to remove any remaining liquid.</li>
	<li>Resuspend the pellet in 45 mL of cold (4-10 &#176;C) S30A buffer using a vortex mixer.</li>
	<li>Weigh an empty 50 mL centrifuge tube, transfer the cells into it, and repeat steps 3.2-3.3 to wash the cells.</li>
	<li>Weigh the pellet, subtracting the weight of an empty 50 mL tube. Make sure to carefully aspirate any remaining supernatant to ensure an accurate measurement of pellet weight. 
	NOTE: A typical yield is ~1.3 g of cell pellet from 400 mL of production culture.</li>
	<li>Add 2 volumes of cold S30A buffer supplemented with 2 mM dithiothreitol, i.e., 2 mL of buffer for every 1 g of cell pellet, and resuspend the cells by vigorously vortex mixing.</li>
	<li>Freeze the cells. Place the 50 mL tube containing the&#160;cells in a -20 &#176;C or -80 &#176;C freezer until the pellet is thoroughly frozen. 
	NOTE: The freezing step is a good stopping point for the day.</li>
	<li>Thaw the cells in a room temperature water bath.</li>
	<li>Vortex vigorously for 2-3 min.</li>
	<li>Incubate at 37 &#176;C for 45 min with shaking at 300 rpm.</li>
	<li>Clear the sample of heavy cellular debris by centrifuging in transparent centrifuge tubes at 30,000 &#215; g for 45 min at 4 &#176;C. 
	NOTE: If a centrifuge capable of 30,000 x g is not available, centrifuge for 45 min at 21,000 &#215; g, and use additional caution in step 3.13, as the pellet will be less compact.</li>
	<li>Carefully transfer the supernatant to a new tube with a pipet, avoiding disturbing the pellet as much as possible. If the transferred supernatant is contaminated with material from the pellet, repeat the previous step.</li>
	<li>Transfer the supernatant to 1.5 mL centrifuge tubes and centrifuge once more at 21,000 &#215; g (or the maximum speed of a tabletop centrifuge) for 5 min.</li>
	<li>Aliquot the cleared autolysate into the desired volumes, carefully avoiding any remaining pellet, and freeze at -80 &#176;C or use immediately. 
	&#8203;NOTE: A single 20 &#181;L reaction uses 8 &#181;L of autolysate.</li>
</ol>
4. Cell-free gene expression
NOTE: The autolysate is now ready for any desired end-use. The following is an example standard protocol for cell-free gene expression.
<ol>
	<li>For a 20 &#181;L reaction, mix on ice 8 &#181;L of autolysate and 8.9 &#181;L of premix. See&#160;NOTE&#160;at the end of the protocol section regarding the optimization of magnesium glutamate and PEG 8000 concentrations.</li>
	<li>Add DNA (e.g., pBEST-OR2-OR1-Pr-UTR1-deGFP-T500 to a final concentration of 8 nM), any other reagents, and water to 20 &#181;L.</li>
	<li>Place the reaction in a 384-well microplate and measure the fluorescence time course and/or endpoints using a plate reader. For green fluorescent protein (GFP), use an excitation wavelength of 485 nm and an emission wavelength of 520 nm.</li>
</ol>
5. Protocol modifications
NOTE: The following modifications of the protocol enable it to serve other applications.
<ol>
	<li>Cell-free gene expression using linear DNA templates
	<ol>
		<li>Perform the steps in section 4, supplementing the reaction with 2.2 &#181;M purified GamS protein (expressed and purified as described12) before the addition of the linear DNA.</li>
	</ol>
	</li>
	<li>Cell-free gene expression incorporating protein degradation
	<ol>
		<li>In step 2.1, use autolysate cells containing the plasmid pACYC-FLAG-dN6-His (see the Table of Materials). In all growth media, additionally include 34 &#181;g/mL chloramphenicol.</li>
		<li>In step 2.3, include 40 &#181;M isopropyl &#946;-D-1-thiogalactopyranoside (IPTG) in the growth medium to induce expression from the plasmid.</li>
		<li>Repeat steps 3.2-3.4 (washing) two additional times (for a total of three washes) to ensure the complete removal of chloramphenicol, which is a translation inhibitor. For the first two washes (step 3.4), substitute S30A buffer with phosphate-buffered saline (pH 7.4).</li>
		<li>In step 4.2, supplement with an additional 3 mM ATP (added from a stock solution of 100 mM ATP in water, pH 7.2) and 4.5 mM magnesium glutamate (using a 1 M stock solution in water) (final concentrations) to compensate for high ATP use by ClpXP, as well as chelation of magnesium by the additional ATP.</li>
	</ol>
	</li>
	<li>Cell-free gene expression using LacZ-based readouts (including colorimetric)
	<ol>
		<li>In step 2.1, use autolysate cells that do not natively express LacZ (see the Table of Materials).</li>
	</ol>
	</li>
	<li>Alternatively, prepare the lysate directly from freeze-dried cells.
	<ol>
		<li>Perform all steps from 1.1 to 3.7.</li>
		<li>Mix 8 &#181;L of cell suspension with 8.9 &#181;L of premix.</li>
		<li>Add plasmid DNA (if desired), other custom reagents, and water to reach a final volume of 20 &#181;L.</li>
		<li>Transfer the reaction to a 384-well microplate and freeze-dry it. 
		NOTE: Freeze-dried samples can be stored for up to a week and possibly longer.</li>
		<li>To begin the reaction, rehydrate it with 18 &#181;L of deionized water supplemented with any desired DNA or other reagents.</li>
		<li>Follow the fluorescence dynamics in a plate reader.</li>
	</ol>
	</li>
</ol>
NOTE&#160;1: Autolysate cells are designed to lyse upon a freeze-thaw cycle, so it is particularly important to use cryoprotectant when making frozen stocks. We froze stocks in 24% wt/vol glycerol and stored them at -80 &#176;C.
NOTE 2: Magnesium ions and PEG 8000 are critical for lysate performance. The base 2.5x premix, based on previously published data, contains 6 mM magnesium glutamate and 4.8% wt/vol PEG 8000, which become 2.4 mM and 1.9%, respectively, in the final reaction. The autolysate prepared with the protocol here typically performs best with an additional 5 mM Mg-glutamate and 1.5% PEG 8000 in the final reaction. However, this can be optimized in the range of an additional 0-10 mM Mg glutamate and an additional 0-3% PEG 8000 (compared to the base premix). To prepare the premix with the recommended additional 5 mM Mg-glutamate and 1.5% PEG 8000 (final concentrations), mix 380 &#181;L of premix with 4.75 &#181;L of magnesium glutamate at 1 M and 36.1 &#181;L of PEG 8000 at 40% weight/volume.

<ol><li>Dudley, Q. M., Karim, A. S., Jewett, M. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cell-free+metabolic+engineering%3A+biomanufacturing+beyond+the+cell%5BTitle%5D)+AND+%22Biotechnology+Journal%22%5BJournal%5D)">Cell-free metabolic engineering: biomanufacturing beyond the cell.</a> Biotechnology Journal. 10 (1), 69-82 (2015).</li>
<li>Smith, M. T., Wilding, K. M., Hunt, J. M., Bennett, A. M., Bundy, B. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+emerging+age+of+cell-free+synthetic+biology%5BTitle%5D)+AND+%22FEBS+Letters%22%5BJournal%5D)">The emerging age of cell-free synthetic biology.</a> FEBS Letters. 588 (17), 2755-2761 (2014).</li>
<li>Casteleijn, M. G., Urtti, A., Sarkhel, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Expression+without+boundaries%3A+cell-free+protein+synthesis+in+pharmaceutical+research%5BTitle%5D)+AND+%22International+Journal+of+Pharmaceutics%22%5BJournal%5D)">Expression without boundaries: cell-free protein synthesis in pharmaceutical research.</a> International Journal of Pharmaceutics. 440 (1), 39-47 (2013).</li>
<li>He, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cell-free+protein+synthesis%3A+applications+in+proteomics+and+biotechnology%5BTitle%5D)+AND+%22New+Biotechnology%22%5BJournal%5D)">Cell-free protein synthesis: applications in proteomics and biotechnology.</a> New Biotechnology. 25 (2-3), 126-132 (2008).</li>
<li>Pardee, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Paper-based+synthetic+gene+networks%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Paper-based synthetic gene networks.</a> Cell. 159 (4), 940-954 (2014).</li>
<li>Pardee, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((low-cost+detection+of+Zika+virus+using+programmable+biomolecular+components%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">low-cost detection of Zika virus using programmable biomolecular components.</a> Cell. 165 (5), 1255-1266 (2016).</li>
<li>Takahashi, M. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Characterizing+and+prototyping+genetic+networks+with+cell-free+transcription-translation+reactions%5BTitle%5D)+AND+%22Methods%22%5BJournal%5D)">Characterizing and prototyping genetic networks with cell-free transcription-translation reactions.</a> Methods. 86, 60-72 (2015).</li>
<li>Siegal-Gaskins, D., Tuza, Z. A., Kim, J., Noireaux, V., Murray, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gene+circuit+performance+characterization+and+resource+usage+in+a+cell-free+%22breadboard%22%5BTitle%5D)+AND+%22ACS+Synthetic+Biology%22%5BJournal%5D)">Gene circuit performance characterization and resource usage in a cell-free "breadboard".</a> ACS Synthetic Biology. 3 (6), 416-425 (2014).</li>
<li>Niederholtmeyer, H., Chaggan, C., Devaraj, N. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Communication+and+quorum+sensing+in+non-living+mimics+of+eukaryotic+cells%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Communication and quorum sensing in non-living mimics of eukaryotic cells.</a> Nature Communications. 9, 5027(2018).</li>
<li>Sun, Z. Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Protocols+for+implementing+an+Escherichia+coli+based+TX-TL+cell-free+expression+system+for+synthetic+biology%5BTitle%5D)+AND+%22Journal+of+Visualized+Experiments%3A+JoVE%22%5BJournal%5D)">Protocols for implementing an Escherichia coli based TX-TL cell-free expression system for synthetic biology.</a> Journal of Visualized Experiments: JoVE. (79), e50762(2013).</li>
<li>Dopp, J., Jo, Y., Reuel, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Methods+to+reduce+variability+in+E.+coli-based+cell-free+protein+expression+systems%5BTitle%5D)+AND+%22Synthetic+and+Systems+Biotechnology%22%5BJournal%5D)">Methods to reduce variability in E. coli-based cell-free protein expression systems.</a> Synthetic and Systems Biotechnology. 4 (4), 204-211 (2019).</li>
<li>Didovyk, A., Tonooka, T., Tsimring, L., Hasty, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rapid+and+scalable+preparation+of+bacterial+lysates+for+cell-free+gene+expression%5BTitle%5D)+AND+%22ACS+Synthetic+Biology%22%5BJournal%5D)">Rapid and scalable preparation of bacterial lysates for cell-free gene expression.</a> ACS Synthetic Biology. 6 (12), 2198-2208 (2017).</li>
<li>Tonooka, T., Niederholtmeyer, H., Tsimring, L., Hasty, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Artificial+cell+on+a+chip+integrated+with+protein+degradation%5BTitle%5D)+AND+%222019+IEEE+32nd+International+Conference+on+Micro+Electro+Mechanical+Systems+%28MEMS%29%22%5BJournal%5D)">Artificial cell on a chip integrated with protein degradation.</a> 2019 IEEE 32nd International Conference on Micro Electro Mechanical Systems (MEMS). , 107-109 (2019).</li>
<li>Garibaldi, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Validation+of+autoclave+protocols+for+successful+decontamination+of+category+A+medical+waste+generated+from+care+of+patients+with+serious+communicable+diseases%5BTitle%5D)+AND+%22Journal+of+Clinical+Microbiology%22%5BJournal%5D)">Validation of autoclave protocols for successful decontamination of category A medical waste generated from care of patients with serious communicable diseases.</a> Journal of Clinical Microbiology. 55 (2), 545-551 (2017).</li>
<li>Cole, S., Miklos, A., Chiao, A., Sun, Z., Lux, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Methodologies+for+preparation+of+prokaryotic+extracts+for+cell-free+expression+systems%5BTitle%5D)+AND+%22Synthetic+and+Systems+Biotechnology%22%5BJournal%5D)">Methodologies for preparation of prokaryotic extracts for cell-free expression systems.</a> Synthetic and Systems Biotechnology. 5 (4), 252-267 (2020).</li>
<li>Fujiwara, K., Doi, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Biochemical+preparation+of+cell+extract+for+cell-free+protein+synthesis+without+physical+disruption%5BTitle%5D)+AND+%22PLoS+ONE%22%5BJournal%5D)">Biochemical preparation of cell extract for cell-free protein synthesis without physical disruption.</a> PLoS ONE. 11 (4), 0154614(2016).</li>
<li>Shin, J., Noireaux, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Efficient+cell-free+expression+with+the+endogenous+E.+coli+RNA+polymerase+and+sigma+factor+70%5BTitle%5D)+AND+%22Journal+of+Biological+Engineering%22%5BJournal%5D)">Efficient cell-free expression with the endogenous E. coli RNA polymerase and sigma factor 70.</a> Journal of Biological Engineering. 4, 8(2010).</li>
</ol>

J.H. is a co-founder of GenCirq Inc, which focus on cancer therapeutics. He is on the Board of Directors and has equity in GenCirq.

The protocol described here yields highly active bacterial lysate for cell-free gene expression. The key is to use cells carrying the plasmid pAD-LyseR, which expresses the lambda phage endolysin cytosolically. These cells are potentiated to lyse themselves upon permeabilization of the inner membrane, allowing the endolysin access to the cell wall, which the method achieves through a simple freeze-thaw cycle. Because the cells effectively lyse themselves, the product is referred to as autolysate. After the cells have lys...

Gene expression in cell-free lysates has several advantages over using live cells1,2,3,4. Lysates can be easily modified biochemically and used in conditions that could be detrimental to or impossible to achieve in live cells. Gene expression circuits do not have to contend or compete with host biological processes, and testing new genetic circuits is as simple as adding DNA. For these reasons, cell-free gene expression has found various applications, from biosensors5,6 to rapidly prototyping synthetic gene circuits7,8 to developing artificial cells9. Most cell-free gene expression utilizes cellular lysates that have been highly processed, generally requiring long and complex protocols, specialized equipment, and/or sensitive steps that can lead to significant variation between users and batches10,11.
This paper describes a simple, efficient method for producing cell-free lysate that requires minimal processing and expertise (Figure 1A)12. The method relies on E. coli cells that are engineered to lyse following a simple freeze-thaw cycle. The cells express an endolysin from phage lambda that degrades the cell wall. As the cells are growing, this endolysin remains in the cytoplasm, sequestered from the cell wall. However, a simple freeze-thaw cycle disrupts the cytoplasmic membrane, releasing the endolysin into the periplasm, where it degrades the cell wall, resulting in rapid cell lysis. The protocol can be completed with only a few hours of hands-on work and requires only a freezer, a centrifuge capable of 30,000 &#215; g (for optimal results; lower speeds can be used with more care not to disturb the pellet), a vortex mixer, and a simple buffer solution. Functional lysate can even be produced by freeze-drying the cells and rehydrating them in situ. However, this method produces lysates with lower activity, presumably&#160;due to the remaining cell debris.
The lysates are highly active for cell-free gene expression, and they can be enhanced in various ways depending on the end use. The rate of protein synthesis can be further increased by concentrating the lysate using standard spin concentrators. Linear DNA can be protected from degradation by adding purified GamS protein. Protein degradation, necessary for more complex circuit dynamics such as oscillation, can be achieved by co-expressing a ClpX hexamer in the autolysate-producing strain13. Finally, LacZ-based visual readouts are enabled by using an autolysate strain lacking lacZ. Overall, this method produces highly active cell-free lysate that is suitable for a wide range of applications.

<table><tbody><tr><td>2xYT media</td><td>EMD Millipore</td><td>4.85008</td><td>or equivalent</td></tr><tr><td>3-PGA</td><td>Sigma Aldrich</td><td>P8877</td><td>or equivalent</td></tr><tr><td>Amicon Ultra-15 centrifugal filter unit, 3 kDa cutoff</td><td>Millipore Sigma</td><td>UFC900308</td><td>optional, can be used to concentrate lysate, select concentrator capacity appropriate for the volume to be concentrated</td></tr><tr><td>ampicillin</td><td>Sigma Aldrich</td><td>A0166-5G</td><td>or carbenicillin, a more stable variant</td></tr><tr><td>ATP</td><td>Sigma Aldrich</td><td>A8937</td><td>or equivalent</td></tr><tr><td>cAMP</td><td>Sigma Aldrich</td><td>A9501</td><td>or equivalent</td></tr><tr><td>CoA</td><td>Sigma Aldrich</td><td>C4282</td><td>or equivalent</td></tr><tr><td>CTP</td><td>United States Biosciences</td><td>14121</td><td>or equivalent</td></tr><tr><td>D-glucose (dextrose)</td><td>Fisher Scientific</td><td>AAA1749603</td><td>or equivalent</td></tr><tr><td>dithiothreitol (DTT)</td><td>Sigma Aldrich</td><td>D0632-1G</td><td>or equivalent</td></tr><tr><td>E. coli BL21-Gold (DE3) carrying pAD-LyseR</td><td>Addgene</td><td>99244</td><td></td></tr><tr><td>E. coli BL21-Gold (DE3) &amp;Delta;lacZ carrying pAD-LyseR</td><td>Addgene</td><td>99245</td><td></td></tr><tr><td>Folinic acid</td><td>Sigma Aldrich</td><td>F7878</td><td>or equivalent</td></tr><tr><td>GTP</td><td>United States Biosciences</td><td>16800</td><td>or equivalent</td></tr><tr><td>HEPES</td><td>Sigma Aldrich</td><td>H3375-25G</td><td>or equivalent</td></tr><tr><td>LB media</td><td>Fisher Scientific</td><td>DF0446075</td><td>or equivalent</td></tr><tr><td>magnesium glutamate</td><td>Sigma Aldrich</td><td>49605-250G</td><td>or equivalent</td></tr><tr><td>NAD</td><td>Sigma Aldrich</td><td>N6522</td><td>or equivalent</td></tr><tr><td>potassium glutamate</td><td>Sigma Aldrich</td><td>G1501-100G</td><td>or equivalent</td></tr><tr><td>potassium hydroxide (KOH)</td><td>Sigma Aldrich</td><td>221473-25G</td><td>for adjusting pH</td></tr><tr><td>potassium phosphate dibasic</td><td>Fisher Scientific</td><td>BP363-500</td><td>or equivalent</td></tr><tr><td>potassium phosphate monobasic</td><td>Fisher Scientific</td><td>BP362-500</td><td>or equivalent</td></tr><tr><td>Spermidine</td><td>Sigma Aldrich</td><td>85558</td><td>or equivalent</td></tr><tr><td>Tris-HCl</td><td>Fisher Scientific</td><td>9310500GM</td><td>or equivalent</td></tr><tr><td>tRNA mix</td><td>Roche</td><td>10109541001</td><td>or equivalent</td></tr><tr><td>UTP</td><td>United States Biosciences</td><td>23160</td><td>or equivalent</td></tr></tbody></table>

rapid, affordable, and uncomplicated production of bacterial cell-free lysate

Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate

Cell-free gene expression offers the power of biology without the complications of a living organism. Although many such gene expression systems exist, most are quite expensive to buy and/or require special equipment and finely honed expertise to produce effectively. This protocol describes a method to produce bacterial cell-free lysate that supports high levels of gene expression, using only standard laboratory equipment and requiring minimal processing. The method uses an Escherichia coli strain producing an endolysin that does not affect growth, but which efficiently lyses a harvested cell pellet following a simple freeze-thaw cycle. The only further processing required is a brief incubation followed by centrifugation to clear the autolysate of cellular debris. Dynamic gene circuits can be achieved through heterologous expression of the ClpX protease in the cells before harvesting. An E. coli strain lacking the lacZ gene can be used for high-sensitivity, cell-free biosensing applications using a colorimetric or fluorescent readout. The entire protocol requires as few as 8-9 hours, with only 1-2 hours of hands-on labor from inoculation to completion. By reducing the cost and time to obtain cell-free lysate, this method should increase the affordability of cell-free gene expression for various applications.

Representative results can be observed by using autolysate to express GFP from a constitutively expressing plasmid, here pBEST-OR2-OR1-Pr-UTR1-deGFP-T500, and recording a time course of GFP fluorescence in a plate reader (Figure 1B). A dilution series of plasmid DNA found strong expression even at 1 nM DNA. Compared to a commercially available lysate, the autolysate can produce a greater total yield and achieved a greater maximum production rate, calculated as the time derivative of the GFP ...

This protocol describes a rapid and simple method to produce bacterial lysate for cell-free gene expression, using an engineered strain of Escherichia coli and requiring only standard laboratory equipment.

Cell-free gene expression offers the power of biology without the complications of a living organism. Although many such gene expression systems exist, ...

rapid-affordable-uncomplicated-production-bacterial-cell-free

Research

JoVE Journal

Biology

In the post-human genomics era, the availability of recombinant proteins in native conformations is crucial to structural, functional and therapeutic research and development. Here, we describe a test- and large-scale protein expression system in human embryonic kidney 293T cells that can be used to produce a variety of recombinant proteins.

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Source: Wiegand, D. J., et al. Cell-free Protein Expression Using the Rapidly Growing Bacterium Vibrio natriegens. J. Vis. Exp. (2019).This video demonstrates the use of a bacterial cell-free protein expression system based on Vibrio natriegens crude lysate to perform coupled in vitro transcription and translation. It highlights the preparation of a master mix with essential components and the step-by-step synthesis of functional proteins from a DNA template.

Cell-Free Protein Expression Using a Bacterial Crude Cell Extract

This protocol details the steps, costs, and equipment necessary to generate E. coli-based cell extracts and implement in vitro protein synthesis reactions within 4 days or less. To leverage the flexible nature of this platform for broad applications, we discuss reaction conditions that can be adapted and optimized.

Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

Cell-free expression systems are powerful and cost-efficient tools for the high-throughput synthesis and screening of important proteins. Here, we describe the preparation of cell-free protein expression system using Vibrio natriegens for the rapid protein production using plasmid DNA, linear DNA, and mRNA template.

Cell-free Protein Expression Using the Rapidly Growing Bacterium Vibrio natriegens

This protocol describes the method, materials, equipment and steps for bottom-up preparation of RNA and protein producing synthetic cells. The inner aqueous compartment of the synthetic cells contained the S30 bacterial lysate encapsulated within a lipid bilayer (i.e., stable liposomes), using a water-in-oil emulsion transfer method.

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer

We present a fast and cost-effective method to produce the recombinant PURE cell-free TX-TL system using standard laboratory equipment.

OnePot PURE Cell-Free System

The study describes a protocol for creating large (µg-mg) quantities of DNA for protein screening campaigns from synthetic gene fragments without cloning or using living cells. The minimal template is enzymatically digested and circularized and then amplified using isothermal rolling circle amplification. Cell-free expression reactions could be performed with the unpurified product.

Rapid, Enzymatic Methods for Amplification of Minimal, Linear Templates for Protein Prototyping using Cell-Free Systems

This work describes the preparation of cell extract from Escherichia coli (E. coli) followed by cell-free protein synthesis (CFPS) reactions in under 24 hours. Explanation of the cell-free autoinduction (CFAI) protocol details improvements made to reduce researcher oversight and increase quantities of cell extract obtained.

From Cells to Cell-Free Protein Synthesis within 24 Hours Using Cell-Free Autoinduction Workflow

Leishmania Translational Extract (LTE) is a eukaryotic cell-free protein expression system derived from the single-celled parasite, Leishmania tarentolae. This optimized protocol makes LTE simple and cost-effective to manufacture. It is suitable for various applications focused on the multiparallel expression and study of complex eukaryotic proteins and their interactions.

Production and Optimization of LTE, a Leishmania tarentolae Derived Cell-Free Protein Expression System for Recombinant Protein Production

This protocol describes the Cell-Free Protein Synthesis (CFPS) system used in constructing synthetic cells. It outlines key stages with representative results in different micro-compartments. The protocol aims to establish best practices for diverse laboratories in the synthetic cell community, advancing progress in synthetic cell development.

Cell-Free Protein Synthesis System for Building Synthetic Cells

We present an updated protocol for the production of the OnePot 'Protein synthesis Using Recombinant Elements' (PURE) system and crude ribosomes for cell-free protein synthesis, focusing on controlling cell growth to minimize batch-to-batch variations.

Refinement of OnePot PURE and Crude Ribosome Production for Reproducible Cell-free Protein Synthesis

Learn a rapid, affordable method for producing bacterial cell-free lysate using an autolysis Escherichia coli strain and standard laboratory equipment. This protocol enables accessible cell-free gene expression for researchers.

Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate

Explore More Videos